Hyponatrémie sévère sous chimiothérapie du carcinome à petites cellules

Garoute, C.; Plouvier, Nathalie; Iacob, E.; Cotrel, R.; Suguenot, R.; Lecuyer, E.; Bentayeb, H.; Douadi, Y.; Dayen, C.

doi:10.1016/j.rmr.2014.07.004

Revue des Maladies Respiratoires

2015

DOI: 10.1016/j.rmr.2014.07.004

|View full text |Cite

Hyponatrémie sévère sous chimiothérapie du carcinome à petites cellules

C. Garoute¹,

Nathalie Plouvier²,

E. Iacob³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Carboplatin/cisplatin

2015

Reactions Weekly

View full text Add to dashboard Cite

S Carboplatin/cisplatin Hyponatraemia due to SIADH: case reportA 68-year-old man with small-cell lung carcinoma developed hyponatraemia due to syndrome of inappropriate anti-diuretic hormone (SIADH) during treatment with cisplatin and then experienced a recurrence during treatment with carboplatin [dosages and routes of administration not stated].The man, who was a smoker, started receiving cisplatin with hydration; his sodium level was 138 mmol/L. On the evening of day 1, he was re-admitted with sudden-onset seizures and coma. He had a blood sodium level of 107 mmol/L, a plasma osmolality of 224 mOsm/kg water, a serum uric acid level of 212 µmol/L; his natriuresis was > 20 mmol/L.The man received treatment including demeclocycline and diuretics with rapid correction of his sodium level and his neurologically symptoms resolved. Cisplatin was replaced by carboplatin at a 75% dose for his second course of chemotherapy; his sodium level was 138 mmol/L. On day 2, he presented with severe hyponatraemia (115 mmol/L) and confusion. His condition resolved. Prior to his third course of chemotherapy, his sodium level was 138 mmol/L. He received carboplatin and developed hyponatraemia again (119 mmol/L) without neurological symptoms. His condition quickly resolved.Author comment: In our case, the patient presented with severe hyponatraemia after each course of chemotherapy. At the time of the first episode of hyponatraemia (day 1 of the first course), his blood sodium level was 107 mmol/L, his calculated plasma osmolality was 224 mOsm/kg of water, and his natriuresis was greater than 20 mmol/L. These results correspond with the criteria for SIADH.

show abstract

Carboplatin/cisplatin

2015

Reactions Weekly

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Hyponatrémie sévère sous chimiothérapie du carcinome à petites cellules

Cited by 1 publication

References 12 publications

Carboplatin/cisplatin

Carboplatin/cisplatin

Contact Info

Product

Resources

About